Based on the analysis of expression profile data of bladder urothelial carcinoma, members of our laboratory have identified several potential biomarkers correlated to the TNM stage and OS of bladder urothelial carcinoma patients, which included CDCA3 [23]. Here, CDCA3 is linked to bladder transitional cell carcinoma.